B Cell Lymphoma

Showing 1 - 25 of 47

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Venetoclax Tablets Crushed and Dissolved Into a Solution

Not yet recruiting
  • Hematologic Malignancy
  • +18 more
  • 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid) of patients prescribed venetoclax as crushed tablets per standard of care.
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Nov 8, 2023

Factors of CMV Reactivation in Patients Receiving of CAR-T Cells

Not yet recruiting
  • Cytomegalovirus Infections
  • +2 more
    • (no location specified)
    Sep 22, 2023

    CAR, B Cell Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Suzhou (ThisCART19A with Dose Level 1, ThisCART19A with Dose Level

    Recruiting
    • CAR
    • +2 more
    • ThisCART19A with Dose Level 1
    • ThisCART19A with Dose Level 2
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Jan 18, 2023

    B Cell Lymphoma, Aggressive Lymphoma, Diffuse Large B Cell Lymphoma Trial in Saint Louis (Mosunetuzumab)

    Recruiting
    • B Cell Lymphoma
    • +5 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jan 3, 2023

    CB-Long-Term Safety Study (CB-LTSS)

    Enrolling by invitation
    • Lymphoma, Non-Hodgkin
    • +7 more
    • Allogeneic CAR-T therapy
    • Irvine, California
    • +3 more
    Nov 18, 2022

    Nasopharyngeal Carcinoma, Castrate Resistant Prostate Cancer, Gastric Cancer Trial in New Haven (APG-5918)

    Recruiting
    • Nasopharyngeal Carcinoma
    • +8 more
    • Springdale, Arkansas
      Highlands Oncology
    Nov 11, 2022

    B Cell Lymphoma Trial in United Kingdom (Varlilumab)

    Active, not recruiting
    • B Cell Lymphoma
    • Manchester, United Kingdom
    • +3 more
    Oct 26, 2022

    B Cell Lymphoma, Acute Lymphoblastic Leukemia, Pediatric, Lymphoma Trial in Stanford (Fludarabine, Cyclophosphamide, Autologous

    Suspended
    • B Cell Lymphoma
    • +2 more
    • Stanford, California
      Stanford Medical Center
    Sep 8, 2022

    Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in United States (CB-010,

    Recruiting
    • Lymphoma, Non-Hodgkin
    • +6 more
    • CB-010
    • +2 more
    • Scottsdale, Arizona
    • +7 more
    Aug 19, 2022

    B Cell Lymphoma Trial in Tel-Aviv (Nivolumab Injection [Opdivo])

    Recruiting
    • B Cell Lymphoma
    • Nivolumab Injection [Opdivo]
    • Tel-Aviv, Israel
      Tel-Aviv Sourasky Medicak center / BMT Unit
    May 22, 2022

    B-Cell Leukemia, B Cell Lymphoma Trial in Kunming (anti-CD19 UCAR-T injection)

    Recruiting
    • B-Cell Leukemia
    • B Cell Lymphoma
    • anti-CD19 UCAR-T injection
    • Kunming, Yunnan, China
      920th Hospital of Joint Logistics Support Force of People's Libe
    Apr 21, 2022

    B Cell Lymphoma Trial in Beijing (SHR-A1912)

    Recruiting
    • B Cell Lymphoma
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Apr 15, 2022

    CART Treatment, B Cell Lymphoma Trial in Tel-Aviv (Eltrombopag)

    Recruiting
    • CART Treatment
    • B Cell Lymphoma
    • Tel-Aviv, Israel
      Tel-Aviv Sourasky Medicak center / BMT Unit
    Apr 14, 2022

    Advanced Solid Tumor, B Cell Lymphoma Trial in Brisbane (CN1)

    Completed
    • Advanced Solid Tumor
    • B Cell Lymphoma
    • Brisbane, Queensland, Austria
      Mater Medical Centre
    Oct 15, 2021

    B Cell Lymphoma Trial in Kunming (CD19 and CD22 targeted prime CAR- T cells)

    Recruiting
    • B Cell Lymphoma
    • CD19 and CD22 targeted prime CAR- T cells
    • Kunming, Yunnnan, China
      920th Hospital of Joint Logistics Support Force
    Jul 30, 2021

    B Cell Lymphoma, B-cell Acute Lymphoblastic Leukemia Trial in Kunming (Anti-CD19 CAR-T Cells Injection)

    Recruiting
    • B Cell Lymphoma
    • B-cell Acute Lymphoblastic Leukemia
    • Anti-CD19 CAR-T Cells Injection
    • Kunming, Yunnan, China
      Kunming Yan'an Hospital
    May 12, 2021

    B Cell Leukemia, B Cell Lymphoma, B-cell Acute Lymphoblastic Leukemia Trial in Guangzhou (CAR-ITNK cells)

    Recruiting
    • B Cell Leukemia
    • +4 more
    • CAR-ITNK cells
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Feb 6, 2021

    B Cell Lymphoma, B Cell Leukemia, Myeloma Trial in Wenzhou (CAR-CD19 T cell, CAR-BCMA T cell, CAR-GPC3 T cell)

    Active, not recruiting
    • B Cell Lymphoma
    • +5 more
    • CAR-CD19 T cell
    • +5 more
    • Wenzhou, Zhejiang, China
      First Affiliated Hospital of Wenzhou Medical University
    Oct 5, 2020

    ALL, B Cell Lymphoma, Leukemia Trial run by the NCI (Anti-Cluster of Differentiation (CD)19-Chimeric antigen receptor (CAR))

    Completed
    • ALL
    • +4 more
    • Anti-Cluster of Differentiation (CD)19-Chimeric antigen receptor (CAR)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 14, 2020

    B Cell Lymphoma Trial in Guangzhou (CD19-targeting CAR T Cells infusion)

    Withdrawn
    • B Cell Lymphoma
    • CD19-targeting CAR T Cells infusion
    • Guangzhou, Guangdong, China
      Central laboratory in Fuda cancer hospital
    Jul 14, 2020

    B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in

    Completed
    • B-cell Chronic Lymphocytic Leukemia
    • +9 more
    • Stanford, California
    • +15 more
    May 14, 2020

    B Cell Leukemia, B Cell Lymphoma Trial in Philadelphia (CART-19)

    Completed
    • B Cell Leukemia
    • B Cell Lymphoma
    • CART-19
    • Philadelphia, Pennsylvania
      CHOP - http://www.chop.edu/service/oncology/pediatric-cancer-res
    Mar 2, 2020

    B Cell Lymphoma Trial in Taiyuan, Tianjin (JHL1101, Rituximab)

    Terminated
    • B Cell Lymphoma
    • JHL1101
    • Rituximab
    • Taiyuan, Shanxi, China
    • +1 more
    Jan 6, 2020

    B Cell Lymphoma, B Cell Leukemia Trial in Chengdu, Shanghai (CD20-CD19 cCAR T cells)

    Unknown status
    • B Cell Lymphoma
    • B Cell Leukemia
    • CD20-CD19 cCAR T cells
    • Chengdu, China
    • +1 more
    Nov 8, 2019

    B Cell Lymphoma, B Cell Leukemia Trial in Chengdu, Shenzhen (CD19 CARvac T cells)

    Unknown status
    • B Cell Lymphoma
    • B Cell Leukemia
    • CD19 CARvac T cells
    • Chengdu, China
    • +1 more
    Nov 8, 2019